Şükrü Anıl Doğan

846 citations
14 papers · 597 indexed · h-index 9
Topics
Mitochondrial Function and Pathology (10 papers)RNA modifications and cancer (3 papers)Metabolism and Genetic Disorders (3 papers)
Partner nations
GermanySwedenTürkiye

In The Last Decade

Şükrü Anıl Doğan

13 papers receiving 587 citations

Peers

Şükrü Anıl Doğan
Comparison fields: 5 of 78
  • Molecular Biology 447
  • Clinical Biochemistry 109
  • Physiology 107
  • Genetics 79
  • Epidemiology 68
Replace Kristen Alexa with:
Kristen Alexa United States
Claire Pujol France
Jin Sook Lee South Korea
Ryota Iwasawa Spain
Rajarshi Chakrabarti United States
Tegan Stait Australia
Rolf J. R. J. Janssen Netherlands
Marris G. Dibley Australia
Shilpa Iyer United States
Şükrü Anıl Doğan relative to Kristen Alexa United States Kristen Alexa's profile →
Citations per field
00.5×2.6×
Kristen Alexa · 1×
Citations per year

Countries citing papers authored by Şükrü Anıl Doğan

Since Specialization
Citations

This map shows the geographic impact of Şükrü Anıl Doğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Şükrü Anıl Doğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Şükrü Anıl Doğan more than expected).

Fields of papers citing papers by Şükrü Anıl Doğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Şükrü Anıl Doğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Şükrü Anıl Doğan. The network helps show where Şükrü Anıl Doğan may publish in the future.

Co-authorship network of co-authors of Şükrü Anıl Doğan

This figure shows the co-authorship network connecting the top 25 collaborators of Şükrü Anıl Doğan. A scholar is included among the top collaborators of Şükrü Anıl Doğan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Şükrü Anıl Doğan. Şükrü Anıl Doğan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 4
2 8
3 16
4 71
5 83
6 62
7 27
8 63
9 177
10 71
11 1
12 2
13 1
14 11

About Şükrü Anıl Doğan

Şükrü Anıl Doğan is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology, having authored 14 papers that have together received 597 indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (10 papers), RNA modifications and cancer (3 papers) and Metabolism and Genetic Disorders (3 papers). The work is most often cited by research in Clinical Biochemistry (109 citations), Aging (23 citations) and Molecular Biology (447 citations). Şükrü Anıl Doğan has collaborated with scholars based in Germany, Sweden and Türkiye. Frequent co-authors include Aleksandra Trifunović, Carlo Viscomi, Massimo Zeviani, Raffaele Cerutti, Rolf Wibom, Katharina Senft, Priyanka Maiti, Alexandra Kukat, Shuaiyu Wang and Steffen Hermans. Their work appears in journals such as Nucleic Acids Research, Molecular Cell and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026